Professor Amir Zarrinpar's seminal paper on engraftable live biotherapeutics is out!! We are commercializing this potentially curative engrafting technology at Endure Bio. biorxiv.org/content/10.110…

Meet us at JP Morgan in San Francisco, January

Our team just applied to @SWC2022 #StartupWorldCup #EndureBio startupworldcup.io

Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics bit.ly/3w2fEkn

Thank you Director Tabak! Endure Bio is developing Zarrinpar Laboratory's technology to treat chronic conditions. Watch this page!! Go Endure Bio! Live engrafting biotherapeutics!

I am very happy to share our recent review article on Methods of DNA introduction for the engineering of commensal microbes. Congrats to Dake, Nicole and thanks to excellent collaboration with Amir Zarrinpar and to support from nick. sciencedirect.com/science/articl…

FOR IMMEDIATE RELEASE Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis.

globenewswire.com/news-release/2…